Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Vaxcyte
PCVX
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$75.51
-3.26
-4.14%
At Close: -
$75.51
0
0.00%
After Hours: 4:01 PM EDT
15 minutes delayed
Get Report
Watch
Vaxcyte (PCVX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Vaxcyte (NASDAQ:PCVX) Stock
Vaxcyte Stock (NASDAQ: PCVX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 28, 2024
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Va...
Benzinga Newsdesk
Thursday, May 09, 2024
Cantor Fitzgerald Reiterates Overweight on Va...
Benzinga Newsdesk
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Vaxcyte Q1 EPS $(0.85) Beats $(1.09) Estimate
Benzinga Newsdesk
Wednesday, April 10, 2024
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
Vandana Singh
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Tuesday, March 12, 2024
Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Mizuho Maintains Buy on Vaxcyte, Raises Price...
Benzinga Newsdesk
Monday, March 04, 2024
Vaxcyte Completes Enrollment Of Phase 2 Study...
Benzinga Newsdesk
Wednesday, February 28, 2024
Needham Maintains Buy on Vaxcyte, Raises Pric...
Benzinga Newsdesk
Tuesday, February 27, 2024
Recap: Vaxcyte Q4 Earnings
Benzinga Insights
Vaxcyte Q4 2023 GAAP EPS $(1.82) Misses $(1.0...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Wednesday, January 31, 2024
Vaxcyte Prices $750M Public Offering Of 10,93...
Benzinga Newsdesk
Tuesday, January 30, 2024
Vaxcyte Commences Proposed Public Offering Of...
Benzinga Newsdesk
Monday, January 29, 2024
Vaxcyte shares are trading higher after the c...
Benzinga Newsdesk
Vaxcyte Completes Enrollment Of Phase 1/2 Stu...
Benzinga Newsdesk
Friday, January 05, 2024
"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
Nabaparna Bhattacharya
Thursday, January 04, 2024
Vaxcyte Provides Clinical And Regulatory Prog...
Benzinga Newsdesk
Tuesday, January 02, 2024
B of A Securities Maintains Buy on Vaxcyte, R...
Benzinga Newsdesk
Thursday, December 07, 2023
Vaccine Player Vaxcyte Can Potentially Disrupt Pfizer's 20-Plus-Year Near Monopoly, Says Analyst
Vandana Singh
Mizuho Initiates Coverage On Vaxcyte with Buy...
Benzinga Newsdesk
Monday, December 04, 2023
VAX-24 Phase 1/2 Adult Proof-Of-Concept Data ...
Benzinga Newsdesk
Thursday, November 30, 2023
Board Member at Vaxcyte Acquires Company Stock Options Worth 30,000 Shares
Benzinga Insights
Monday, November 27, 2023
Vaxcyte Exercises Option And Enters Into Manu...
Benzinga Newsdesk
Thursday, November 09, 2023
Vaxcyte Doses First Participants In Phase 1/2...
Benzinga Newsdesk
Tuesday, November 07, 2023
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Monday, November 06, 2023
Vaxcyte Q3 EPS $(0.91) Misses $(0.84) Estimat...
Benzinga Newsdesk
Thursday, October 19, 2023
Vaxcyte Announces FDA Clearance Of Investigat...
Benzinga Newsdesk
Tuesday, October 17, 2023
Chief Operating Officer at Vaxcyte Exercises Options Worth $234K
Benzinga Insights
Monday, October 16, 2023
Vaxcyte And Lonza Expand Collaboration For Gl...
Benzinga Newsdesk
Wednesday, September 27, 2023
Vaxcyte Chief Operating Officer Acquires 3,000 Shares After Exercising Company Stock Options
Benzinga Insights
Tuesday, August 22, 2023
Cantor Fitzgerald Reiterates Overweight on Va...
Benzinga Newsdesk
Wednesday, August 09, 2023
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Tuesday, August 08, 2023
Vaxcyte Q2 EPS $(0.70) Beats $(0.74) Estimate
Benzinga Newsdesk
Tuesday, July 11, 2023
Vaxcyte Advances To Second Stage Of Ongoing P...
Benzinga Newsdesk
Tuesday, May 09, 2023
Needham Reiterates Buy on Vaxcyte, Maintains ...
Benzinga Newsdesk
Monday, May 08, 2023
Vaxcyte Q1 EPS $(0.70) Beats $(0.83) Estimate
Happy Mohamed
Monday, May 01, 2023
Vaxcyte shares are trading higher. The compan...
Benzinga Newsdesk
Thursday, April 20, 2023
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Ryan Glosier
Wednesday, April 19, 2023
Vaxcyte shares are trading higher after the c...
Bill Haddad
Vaxcyte Raises $500M Via Secondary Stock Offe...
Benzinga Newsdesk
Tuesday, April 18, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Benzinga Insights
TD Cowen Initiates Coverage On Vaxcyte with O...
Benzinga Newsdesk
B of A Securities Maintains Buy on Vaxcyte, R...
Benzinga Newsdesk
Monday, April 17, 2023
Why Vaxcyte Stock Is Sliding After Hours
Adam Eckert
Vaxcyte Announces Commencement Of Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Size Or Amount Disclosed
Happy Mohamed
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Vaxcyte shares are trading higher after the c...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch